DOUGLAS RICHARD LABRECQUE, MD
Osteopathic Medicine at Hawkins Dr, Iowa City, IA

License number
Iowa 20677
Category
Osteopathic Medicine
Type
Hepatology
Address
Address
200 Hawkins Dr, Iowa City, IA 52242
Phone
(319) 356-1660
(319) 356-7918 (Fax)

Professional information

Douglas Richard Labrecque Photo 1

Douglas Richard Labrecque, Iowa City IA

Specialties:
Internist
Address:
200 Hawkins Dr, Iowa City, IA 52242
Education:
Stanford University, School of Medicine - Doctor of Medicine
Yale New Haven Psychiatric Hospital - Fellowship - Hepatology
Duke University Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine


Douglas R Labrecque Photo 2

Dr. Douglas R Labrecque, Iowa City IA - MD (Doctor of Medicine)

Specialties:
Internal Medicine
Address:
University Of Iowa Hospital-GAS
200 Hawkins Dr, Iowa City 52242
(319) 356-3127 (Phone)
Languages:
English
Hospitals:
University Of Iowa Hospital-GAS
200 Hawkins Dr, Iowa City 52242
University of Iowa Hospital and Clinics
200 Hawkins Dr, Iowa City 52242
Education:
Medical School
Stanford University School Of Medicine
Graduated: 1970
Duke University Med Center
Graduated: 1971
Graduated: 1975
National Cancer Institute
Graduated: 1974
Yale New Haven
Graduated: 1977


Douglas Richard Labrecque Photo 3

Douglas Richard Labrecque, Iowa City IA

Specialties:
Internal Medicine, Gastroenterology, Hepatology
Work:
University Of Iowa Hospital & Clinic
200 Hawkins Dr, Iowa City, IA 52243
Education:
Stanford University (1970)


Douglas Labrecque Photo 4

Hepatitis C Virus Fc-Binding Function

US Patent:
5846735, Dec 8, 1998
Filed:
Apr 18, 1996
Appl. No.:
8/634545
Inventors:
Jack T. Stapleton - Iowa City IA
Jian-Qiu Han - Shanghai, CN
Douglas LaBrecque - Iowa City IA
Warren N. Schmidt - Iowa City IA
Assignee:
University of Iowa Research Foundation - Iowa City IA
International Classification:
G01N 3353, G01N 33576, C07K 1600, C07K 14735
US Classification:
435 71
Abstract:
The present invention involves the detection and purification of Hepatitis C Virus (HCV). More particularly, the invention involves the exploitation of a newly discovered Fc-binding function in HCV to capture HCV from infected samples. This permits greatly simplified methods of diagnosis, improved methods of treatment and, in addition, the first opportunity to purify significant quantities of HCV.